The 2nd International conference on Bio Equivalence & Bio Availability -2019 is dedicated to biotechnology, drug discovery, pharmacy, biomedicals.
The 2nd International conference on Bio Equivalence & Bio Availability -2019 covers topics such as:
- Drug Discovery, Development and Posology
- Drug Targeting and Drug Development
- Clinical Research
- Bioavailability and Bioequivalence studies
- Food and Nutritional Toxicology
- Drug Toxicology and Interaction
- Immunopharmacology and Immunotoxicology
- Genetic and Molecular Toxicology
- Novel Drug Delivery System
- Neuro and Cardiovascular Pharmacology
- Pharmaceutical Formulations
- Pharmaceutical Analysis
- Pharmacokinetics and Pharmacodynamics
- Pharmacogenetics and Pharmacogenomics
- Pharmacology and Toxicology
- Pharmacokinetics between Pediatric and Geriatrics
- Pharmacovigilance
- Pharmacotherapeutics and Drug Toxicity
- Chromatography
- Psychopharmacology and Pharmacoepidemiology
- Nanomedicals
- Spectrometry
- Bioanalysis and Microbiology
- Analytical Biochemical Techniques
- Regulatory Requirements Of Pharmaceutical Products
- Clinical Cancer Trials
- Challenges in Drug design
- Bioequivalence Study Protocols
- Nutrient Bioavailability
- Clinical Research Vs Clinical Trails
- Surgery And Anesthesiology
- Advances in Assessment of Bioequivalence
- Computational Biomedicines
The 2nd International conference on Bio Equivalence & Bio Availability -2019 brings together:
- Academic professionals
- CEOs, CROs, Directors, Managers and research associates
- Regulatory and Clinical Scientists
- Industrial Scientists
- Students and Postdoctoral Fellows
- Researchers, Education providers
- Government Agencies
- Pharmacists
- Clinical Pharmacologists
- Medical Practitioners
- Molecular and Cellular Pharmacologists
- Clinical Toxicologists
